A retrospective study of safety of palbociclib, abemaciclib, or ribociclib in metastatic breast cancer patients
Latest Information Update: 22 Aug 2022
At a glance
- Drugs Abemaciclib (Primary) ; Palbociclib (Primary) ; Ribociclib (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
Most Recent Events
- 22 Aug 2022 New trial record
- 01 Aug 2022 Results published in the Current Medical Research and Opinion